ArticleProceedings of the National Academy of Sciences of the United States of America2025

Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.

Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.